- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
191
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
191 companies
Nanoform Finland Oyj
Market Cap: €84.0m
Engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States.
NANOFH
€0.98
7D
14.1%
1Y
-39.4%
PExA
Market Cap: €9.6m
Develops and commercializes diagnostic products in various respiratory diseases.
FA0
€0.012
7D
-22.6%
1Y
-57.7%
Ventyx Biosciences
Market Cap: US$199.7m
A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.
VTYX
US$2.75
7D
19.0%
1Y
15.1%
Crescita Therapeutics
Market Cap: CA$9.0m
A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.
CTX
CA$0.47
7D
4.4%
1Y
-22.1%
Kezar Life Sciences
Market Cap: US$28.5m
A clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States.
KZR
US$3.80
7D
1.6%
1Y
-30.8%
Century Therapeutics
Market Cap: US$41.9m
A clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.
IPSC
US$0.48
7D
-1.5%
1Y
-68.3%
Alto Neuroscience
Market Cap: US$105.1m
Operates as a clinical-stage biopharmaceutical company in the United States.
ANRO
US$3.88
7D
1.6%
1Y
-67.0%
Pyxis Oncology
Market Cap: US$135.8m
A clinical stage company, engages in the development of therapeutics to treat solid tumors.
PYXS
US$2.17
7D
-1.8%
1Y
-38.2%
JW (Cayman) Therapeutics
Market Cap: HK$1.7b
A clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China.
2126
HK$4.14
7D
-18.2%
1Y
202.2%
BerGenBio
Market Cap: NOK 47.5m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory disease in Norway.
BGBIO
NOK 1.24
7D
4.4%
1Y
-87.1%
Argenica Therapeutics
Market Cap: AU$34.7m
A biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia.
AGN
AU$0.27
7D
-6.9%
1Y
-63.5%
Algorae Pharmaceuticals
Market Cap: AU$13.5m
A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.
1AI
AU$0.008
7D
14.3%
1Y
14.3%
genOway Société anonyme
Market Cap: €28.1m
A biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide.
ALGEN
€3.05
7D
9.7%
1Y
-21.0%
Level Bio
Market Cap: SEK 22.6m
Manufactures and distributes cutting-edge solutions in the Nordic region and internationally.
LEVBIO
SEK 0.32
7D
-1.8%
1Y
11.0%
Prelude Therapeutics
Market Cap: US$58.3m
A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.
PRLD
US$1.17
7D
12.5%
1Y
-43.8%
China Health Group
Market Cap: HK$164.2m
An investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.
8225
HK$0.18
7D
17.1%
1Y
68.2%
Vinci Gen
Market Cap: zł3.1m
Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.
VGN
zł0.30
7D
-16.2%
1Y
-40.0%
ALX Oncology Holdings
Market Cap: US$67.5m
A clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.
ALXO
US$1.55
7D
47.6%
1Y
-14.4%
Acumen Pharmaceuticals
Market Cap: US$74.5m
A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.
ABOS
US$1.27
7D
1.6%
1Y
-45.7%
XBiotech
Market Cap: US$88.7m
A biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases.
XBIT
US$2.78
7D
4.1%
1Y
-57.6%
PharmaTher Holdings
Market Cap: CA$32.8m
A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.
PHRM
CA$0.37
7D
-3.9%
1Y
48.0%
AbCellera Biologics
Market Cap: US$1.5b
Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
ABCL
US$4.77
7D
4.4%
1Y
95.5%
Avant Brands
Market Cap: CA$9.0m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$0.84
7D
3.7%
1Y
-23.6%
Ovid Therapeutics
Market Cap: US$89.6m
A biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States.
OVID
US$1.40
7D
20.7%
1Y
25.0%
Athira Pharma
Market Cap: US$16.6m
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
ATHA
US$4.07
7D
7.7%
1Y
-6.8%
Seer
Market Cap: US$132.2m
A life sciences company, develops and commercializes products to decode the biology of the proteome.
SEER
US$2.25
7D
9.2%
1Y
31.6%
Captor Capital
Market Cap: CA$1.8m
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.47
7D
0%
1Y
n/a
Addex Therapeutics
Market Cap: CHF 6.7m
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland.
ADXN
CHF 0.068
7D
0%
1Y
-8.9%
PlantArc Bio
Market Cap: ₪6.9m
Operates as an Ag-Bio company for the crop protection and yield enhancement.
PLNT
₪2.08
7D
-0.5%
1Y
2.2%
Dimerix
Market Cap: AU$312.1m
A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.
DXB
AU$0.52
7D
-2.8%
1Y
33.3%
Matricelf
Market Cap: ₪84.6m
A biotechnology company, develops a platform for autologous tissue engineering for various medical conditions.
MTLF
₪4.68
7D
-9.0%
1Y
38.2%
Vaxil Bio
Market Cap: CA$520.5k
A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.
VXL
CA$0.20
7D
-4.9%
1Y
n/a
Cizzle Biotechnology Holdings
Market Cap: UK£7.1m
Operates as a cancer diagnostics company in the United Kingdom.
CIZ
UK£0.018
7D
12.5%
1Y
-14.3%
MacroGenics
Market Cap: US$104.9m
A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.
MGNX
US$1.72
7D
12.4%
1Y
-43.4%
Synlogic
Market Cap: US$20.4m
A biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States.
SYBX
US$1.70
7D
-0.5%
1Y
12.7%
Cytek Biosciences
Market Cap: US$472.0m
A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
CTKB
US$3.41
7D
-13.0%
1Y
-32.6%